Biotech Companies Enhancing Drug Development Process with AI

Biotech companies, such as Generate Biomedicines and Montai, are utilizing artificial intelligence (AI) to enhance the drug development process. Generatehas trained their AI to design new proteins that do not exist in nature, expanding the scope of disease-treating proteins. They have already generated approximately 5 million of these proteins and are focusing on autoimmune conditions, cancer, and infectious diseases. The company's AI-assisted drugs for asthma and a COVID-19 monoclonal antibody treatment are entering the first phase of clinical trials. Similarly, …

artificial artificial intelligence biotech companies design development disease drug development generate generated intelligence nature process proteins